Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Invasive Breast Cancer × Trastuzumab × Clear all

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 41 Stomach Neoplasms 7 Neoplasm Metastasis 4 HER2-positive Breast Cancer 4 Solid Tumors 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Cancer 1 Patient Compliance 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms, Second Primary 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Breast Cancer With a Isolated Brain Progression 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Invasive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Breast Cancer Invasive 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Surgical Procedures, Operative 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Trastuzumab 1 Radiotherapy 1 Indocyanine Green 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡